You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

advanced colorectal cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Colorectal Cancer Trial in Hangzhou (Cetuximab Dabrafenib Tislelizumab)

Not yet recruiting
  • Advanced Colorectal Cancer
  • Cetuximab Dabrafenib Tislelizumab
  • Hangzhou, Zhejing, China
    Zhejiang Cancer Institute & Hospital
Jul 19, 2023

Advanced Colorectal Cancer Trial in Hangzhou (Fruquintinib Combined With Chemotherapy)

Not yet recruiting
  • Advanced Colorectal Cancer
  • Fruquintinib Combined With Chemotherapy
  • Hangzhou, Zhejing, China
    Zhejiang Cancer Institute & Hospital
Jun 29, 2023

Colon Cancer, Neoadjuvant Therapy, Immunotherapy Trial in Guangzhou (Envafolimab, CAPEOX)

Recruiting
  • Colon Cancer
  • +2 more
  • Guangzhou, Guangdong, China
    Sun Yat-Sen University Cancer Center
Aug 26, 2023

Colorectal Cancer Trial in Shanghai (FOLFIRI+Bevacizumab)

Recruiting
  • Colorectal Cancer
  • Shanghai, Pudong, China
    Affiliated Cancer Hospital of Fudan University
Jul 24, 2023

Colorectal Cancer, Liver Metastases, MSS Trial (Sinti+Rego+Cele)

Not yet recruiting
  • Colorectal Cancer
  • +2 more
  • (no location specified)
Jul 3, 2023

Advanced Colorectal Cancer Trial in Guangzhou

Recruiting
  • Advanced Colorectal Cancer
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Center
    Feb 7, 2023

    Colorectal Cancer Trial in Tai'an (Tas-102(Suyuan) combined with bevacizumab)

    Not yet recruiting
    • Colorectal Cancer
    • Tas-102(Suyuan) combined with bevacizumab
    • Tai'an, Shandong, China
      The Second Affiliated Hospital of Shandong First Medical Univers
    Oct 14, 2023

    Advanced Colorectal Carcinoma Trial in Beijing (palliative care group first-line scheme+compound kushen injection, palliative

    Recruiting
    • Advanced Colorectal Carcinoma
    • palliative care group first-line scheme+compound kushen injection
    • palliative care group first-line scheme
    • Beijing, China
      Guang 'anmen Hospital, China Academy of Chinese Medical Sciences
    Jun 7, 2023

    Colorectal Cancer Trial in Hangzhou (RC48-ADC plus Bevacizumab)

    Not yet recruiting
    • Colorectal Cancer
    • RC48-ADC plus Bevacizumab
    • Hangzhou, Zhejinag, China
      The second affiliated hospital of Zhejiang University
    Mar 24, 2023

    TAS-102 in Combination With Regorafenib or Fruquintinib for

    Not yet recruiting
    • TAS 102
    • +3 more
    • (no location specified)
    Aug 7, 2023

    Locally Advanced Colorectal Cancer Trial (Capecitabine, Oxaliplatin, Bevacizumab)

    Not yet recruiting
    • Locally Advanced Colorectal Cancer
    • (no location specified)
    Oct 18, 2022

    Acceptance and Commitment Therapy, Mental Health, Cognitive Impairment,Colorectal Cancer Trial in Alexandria (Acceptance and

    Completed
    • Acceptance and Commitment Therapy, Mental Health, Cognitive Impairment,Colorectal Cancer
    • Acceptance and Commitment Therapy
    • Alexandria, Egypt
      Faculty of Nursing
    Feb 14, 2023

    Locally Advanced Colorectal Carcinoma Trial in Beijing (Cadonilimab, FOLFOX regimen)

    Recruiting
    • Locally Advanced Colorectal Carcinoma
    • Beijing, Beijing, China
      Cancer Hospital/ National Cancer Center, Chinese Academy of Medi
    Nov 23, 2023

    Colorectal Cancer Trial (HR070803 plus oxaliplatin, 5-FU/LV, bevacizumab, HR070803 simulator plus oxaliplatin, 5-FU/LV,

    Not yet recruiting
    • Colorectal Cancer
    • HR070803 plus oxaliplatin, 5-FU/LV, bevacizumab
    • HR070803 simulator plus oxaliplatin, 5-FU/LV, bevacizumab
    • (no location specified)
    Jul 13, 2023

    Colorectal Cancer Trial in Stockholm, Västerås (pTTL)

    Recruiting
    • Colorectal Cancer
    • Stockholm, Sweden
    • +1 more
    Jun 7, 2023

    Advanced Colorectal Carcinoma Trial in Beijing (OH2, Capecitabine, Bevacizumab)

    Not yet recruiting
    • Advanced Colorectal Carcinoma
    • OH2
    • +2 more
    • Beijing, Beijing, China
      National Cancer Center/Cancer Hospital, Chinese Academy of Medic
    Jan 28, 2023

    Colorectal Cancer Trial in Taipei (Robotic surgery)

    Recruiting
    • Colorectal Cancer
    • Robotic surgery
    • Taipei, Taiwan
      Jin-Tung LIANG
    Jul 27, 2023

    Colorectal Cancer Trial in Hangzhou (Ametumumab, Anti-PD-1 mAb, Cetuximab)

    Not yet recruiting
    • Colorectal Cancer
    • Hangzhou, Zhejiang, China
      Sir Run Run Shaw Hospital, Zhejiang University School of Medicin
    Jan 30, 2023

    Colorectal Tumors Trial in Wuhan (Surufatinib)

    Recruiting
    • Colorectal Neoplasms
    • Chohort 1: Surufatinib
    • +2 more
    • Wuhan, Hubei, China
      Hubei Cancer Hospital
    Nov 5, 2022

    Immune Checkpoints in Intraabdominal Ascites Fluid

    Completed
    • Colorectal Cancer
    • Flow-cytometric analysis
    • Istanbul, Turkey
      Ufuk Oguz Idiz
    Dec 4, 2022

    Colorectal Cancer, Chinese Herbal Medicine, Progression-free Survival Trial in China (Brucea javanica oil emulsion injection,

    Recruiting
    • Colorectal Cancer
    • +3 more
    • Brucea javanica oil emulsion injection
    • The best supportive treatment
    • Guangzhou, Guangdong, China
    • +3 more
    Jun 1, 2023

    Colorectal Cancer Trial in New York (mAb hu3S193)

    Terminated
    Has Results
    • Colorectal Cancer
    • monoclonal antibody hu3S193
    • New York, New York
      Memorial Sloan-Kettering Cancer Center
    Oct 3, 2022

    Colorectal Cancer Trial in Shanghai (VIC, Bevacizumab Plus Chemotherapy)

    Recruiting
    • Colorectal Cancer
    • VIC
    • Bevacizumab Plus Chemotherapy
    • Shanghai, China
      Department of General Surgery, Zhongshan Hospital, Fudan Univers
    Sep 14, 2022

    Colorectal Cancer Trial in Guangzhou (mFOLFOXIRI + Cadonilimab, mFOLFOX6)

    Not yet recruiting
    • Colorectal Cancer
    • Guangzhou, Guangdong, China
      Gastrointestinal Hospital, Sun Yat-sen University
    Oct 17, 2022

    Advanced Colorectal Cancer Trial (Bevacizumab combined with Oxaliplatin and TAS-102)

    Not yet recruiting
    • Advanced Colorectal Cancer
    • Bevacizumab combined with Oxaliplatin and TAS-102
    • (no location specified)
    May 16, 2022